- Home
- ALEC vs EIC Comparison
ALEC vs EIC Comparison
Compare ALEC & EIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALEC | EIC |
|---|---|---|
| Founded | 2013 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 194.3M | 228.8M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | ALEC | EIC |
|---|---|---|
| Price | $1.86 | $9.98 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 3 |
| Target Price | $4.83 | ★ $12.63 |
| AVG Volume (30 Days) | ★ 875.1K | 86.3K |
| Earning Date | 05-04-2026 | 05-27-2026 |
| Dividend Yield | N/A | ★ 13.25% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $21,045,000.00 | N/A |
| Revenue This Year | $2.03 | N/A |
| Revenue Next Year | $29.87 | N/A |
| P/E Ratio | ★ N/A | $9.08 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.09 | $9.17 |
| 52 Week High | $3.40 | $13.92 |
Technical Indicators
Market Signals| Indicator | ALEC | EIC |
|---|---|---|
| Relative Strength Index (RSI) | 52.52 | 39.36 |
| Support Level | $1.14 | $9.78 |
| Resistance Level | $2.64 | $10.15 |
| Average True Range (ATR) | 0.15 | 0.17 |
| MACD | 0.05 | -0.04 |
| Stochastic Oscillator | 78.69 | 13.92 |
Price Performance
Historical ComparisonAbout ALEC Alector Inc.
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.
About EIC Eagle Point Income Company Inc.
Eagle Point Income Co Inc is a closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation. The Company seeks to achieve its investment objectives by investing in junior debt tranches of collateralized loan obligations, or "CLOs," that are collateralized by a portfolio consisting of below-investment grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.